AQUESTIVE THERAPEUTICS INC (AQST) Stock News

NASDAQ:AQST - US03843E1047 - Common Stock

3.785 USD

-0.04 (-1.17%)

Last: 8/29/2025, 1:17:06 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AQST Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

3 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Upcoming September Investor Conferences

15 days ago - By: Benzinga - Mentions: ELV BIIB INSM XRAY ...

10 Health Care Stocks Whale Activity In Today's Session

15 days ago - By: Zacks Investment Research - Mentions: ABUS

Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?

21 days ago - By: Benzinga

Uncovering Potential: Aquestive Therapeutics's Earnings Preview

15 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock

15 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock

15 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film

15 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film

18 days ago - By: Zacks Investment Research

Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key Metrics

18 days ago - By: Zacks Investment Research - Mentions: VYNE

Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates

18 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

18 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

25 days ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Report Second Quarter 2025 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

a month ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer

a month ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Names Sherry Korczynski as Chief Commercial Officer

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Provides International Expansion Update for Anaphylm™ (epinephrine) Sublingual Film

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

2 months ago - By: Yahoo Finance - Mentions: APLS

H.C. Wainwright Reaffirms Buy on Aquestive Therapeutics, Inc. (AQST) After FDA Approval

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm™ (epinephrine) Sublingual Film at the CFAAR Food Allergy Summit

2 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions

3 months ago - By: Yahoo Finance - Mentions: BNTX AES TSLA MRNA ...

BioNTech Strengthens UK Ties with Investment of Up to $1.33 Billion

3 months ago - By: Yahoo Finance - Mentions: ATYR ATAI IBRX

aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential

3 months ago - By: Yahoo Finance - Mentions: LXRX PAHC MMSI ITGR ...

Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential

3 months ago - By: Yahoo Finance

Aquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside Potential

4 months ago - By: Zacks Investment Research

Aquestive Therapeutics (AQST) Reports Q1 Earnings: What Key Metrics Have to Say

4 months ago - By: Zacks Investment Research - Mentions: CASI

Aquestive Therapeutics (AQST) Reports Q1 Loss, Lags Revenue Estimates

4 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Aquestive Therapeutics, Inc.

Aquestive Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

4 months ago - By: Yahoo Finance - Mentions: BROS CART ATKR TFC ...

Is Dutch Bros Inc. (BROS) Among the Best Restaurant Stocks to Buy According to Hedge Funds?

4 months ago - By: Zacks Investment Research - Mentions: COLL

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates